SetPoint Medical Corporation
9 clinical trials · Sponsor
◉ Watch SetPoint Medical Corporation
| Record | Firm | Date |
|---|---|---|
| The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study (NCT06796504) | SetPoint Medical Corporation | 2026-04-17 |
| The SetPoint System Safety & Performance Post-Approval Study (NCT07489326) | SetPoint Medical Corporation | 2026-04-15 |
| Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis (NCT04539964) | SetPoint Medical Corporation | 2021-01-11 |
| Long Term Extension of Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA) (NCT04862117) | SetPoint Medical Corporation | 2018-07-28 |
| Safety and Efficacy of Vagus Nerve Stimulator in Patients With Rheumatoid Arthritis (RA) (NCT03437473) | SetPoint Medical Corporation | 2018-03-06 |
Track SetPoint Medical Corporation automatically
Every clearance here is in the API, with alerts when new ones post.